OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Enflonsia

clesrovimab-cfor

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Enflonsia
Proper name
clesrovimab-cfor
Licence type
351(a)
BLA number
761432
Applicant
Merck Sharp & Dohme LLC
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
105MG/0.7ML Injection Intramuscular Pre-Filled Syringe Rx June 9, 2025

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity